CC chemokine receptor-2A is frequently overexpressed in glioblastoma

Journal of Neuro-Oncology

Volumn 86, Issue 2, 2008, Pages 153-163

  Liang, Yu ^a,b   Bollen, Andrew W ^a   Gupta, Nalin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b APPLIED BIOSYSTEMS   (United States)

Author keywords

CCR2; Cytokine receptor; Glioblastoma; MCP 1; Microarray; Migration

Indexed keywords

CHEMOKINE RECEPTOR CCR2; COMPLEMENTARY DNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; BRAIN TISSUE; CANCER CELL; CANCER CELL CULTURE; CANCER INFILTRATION; CELL INFILTRATION; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DNA MICROARRAY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VITRO STUDY; MACROPHAGE; MONOCYTE; NERVE CELL; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; TREATMENT OUTCOME;

ASTROCYTES; BRAIN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL2; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; OLIGODENDROGLIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CCR2; REFERENCE VALUES;

EID: 37249008629     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9463-7     Document Type: Article

References (33)

1. Prados MD, Levin V (2000) Biology and treatment of malignant glioma. Semin Oncol 27(3 Suppl 6):1-10
2. Nagane M, Huang HJ, Cavenee WK (1997) Advances in the molecular genetics of gliomas. Curr Opin Oncol 9(3):215-222
3. Liang Y, Diehn M, Watson N et al (2005) Gene expression profiling reveals clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 102(16):5814-5819
4. Che X, Ye W, Panga L, Wu DC, Yang GY (2001) Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 902(2):171-177
5. Little AR, Benkovic SA, Miller DB, O'Callaghan JP (2002) Chemically induced neuronal damage and gliosis: Enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines(1). Neuroscience 115(1):307-320
6. Desbaillets I, Tada M, de Tribolet N et al (1994) Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer 58(2):240-247
7. Leung SY, Wong MP, Chung LP, Chan AS, Yuen ST (1997) Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol (Berl) 93(5):518-527
8. Platten M, Kretz A, Naumann U et al (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 54(3):388-392
9. Frei K, Siepl C, Groscurth P et al (1987) Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17(9):1271-1278
10. Monteclaro FS, Charo IF (1996) The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J Biol Chem 271(32):19084-19092
11. Lu B, Rutledge BJ, Gu L et al (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187(4):601-608
12. Boring L, Gosling J, Chensue SW et al (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100(10):2552-2561
13. Kurihara T, Warr G, Loy J, Bravo R (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186(10):1757-1762
14. Kuziel WA, Morgan SJ, Dawson TC et al (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 94(22):12053-12058
15. Peters W, Charo IF (2001) Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: Lessons from knockout mice. Curr Opin Lipidol 12(2):175-180
16. Charo IF, Myers SJ, Herman A et al (1994) Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A 91(7):2752-2756
17. Bartoli C, Civatte M, Pellissier JF, Figarella-Branger D (2001) CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies. Acta Neuropathol (Berl) 102(4):385-392
18. Tanaka S, Green SR, Quehenberger O (2002) Differential expression of the isoforms for the monocyte chemoattractant protein-1 receptor, CCR2, in monocytes. Biochem Biophys Res Commun 290(1):73-80
19. Sanders SK, Crean SM, Boxer PA et al (2000) Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J Immunol 165(9):4877-4883
20. Tran PB, Miller RJ (2003) Chemokine receptors: Signposts to brain development and disease. Nat Rev Neurosci 4(6):444-455
21. Andjelkovic AV, Song L, Dzenko KA, Cong H, Pachter JS (2002) Functional expression of CCR2 by human fetal astrocytes. J Neurosci Res 70(2):219-231
22. Banisadr G, Queraud-Lesaux F, Boutterin MC et al (2002) Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem 81(2):257-269
23. Stanimirovic D, Satoh K (2000) Inflammatory mediators of cerebral endothelium: A role in ischemic brain inflammation. Brain Pathol 10(1):113-126
24. Sonoda Y, Ozawa T, Hirose Y et al (2001) Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 61(13):4956-4960
25. Liang Y, Haring M, Roughley PJ, Margolis RK, Margolis RU (1997) Glypican and biglycan in the nuclei of neurons and glioma cells: Presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J Cell Biol 139(4):851-864
26. Maus UA, Herold S, Schlingensiepen KH et al (2000) Antisense oligomers for selective suppression of MCP-1 synthesis in human pulmonary endothelial cells. Antisense Nucleic Acid Drug Dev 10(3):185-193
27. Sun L, Hui AM, Su Q et al (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9(4):287-300
28. Bredel M, Bredel C, Juric D et al (2005) Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65(19):8679-8689
29. Schwamborn J, Lindecke A, Elvers M et al (2003) Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells. BMC Genomics 4(1):46
30. Conti I, Rollins BJ (2004) CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 14(3):149-154
31. Barbero S, Bonavia R, Bajetto A et al (2003) Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63(8):1969-1974
32. Khodarev NN, Labay E, Darga T et al (2004) Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis. Int J Cancer 109(2):214-219
33. Huang R, Lin Y, Wang CC et al (2002) Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res 62(10):2806-2812